The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Surgical Technique, Open Versus Minimally-invasive Gastrectomy After CHemotherapy
Official Title: The STOMACH Trial: Surgical Technique, Open Versus Minimally-invasive Gastrectomy After CHemotherapy
Study ID: NCT02130726
Brief Summary: Laparoscopic surgery has been shown to provide important advantages in comparison with open procedures in the treatment of several malignant diseases, such as less peri-operative blood loss, faster patient recovery and shorter hospital stay. All while maintaining similar results with regard to tumour resection margin and oncological survival. In gastric cancer the role of laparoscopic surgery remains unclear. Current recommended treatment for gastric cancer consists of radical resection of the stomach, combined with lymfadenectomy. The extent of lymfadenectomy is considered a marker for radicality of surgery and quality of care. Therefore, It is imperative that a new surgical technique should be non-inferior with regard to radicality and lymph node yield. Preliminary studies show promising results for laparoscopic gastrectomy, but the number of studies is small and due to lower incidence of gastric cancer in the West they are often underpowered. A prospective randomised clinical trial is indicated in order to establish the optimal surgical technique in gastric cancer: open versus minimally invasive gastrectomy. Results of the STOMACH trial will further aid in determining the optimal surgical technique in patients with gastric cancer.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Universitätsklinikum Carl Gustav Carus, Dresden, , Germany
Academic Medical Centre, Amsterdam, NH, Netherlands
VU Medical Center, Amsterdam, Nlnh, Netherlands
Hospital universitari Basurto, Bilbao, , Spain
Hospital Jerez de la Frontera, Cadiz, , Spain
Hospital Universitario de Josep Trueta, Girona, , Spain
Hospital Universitario del Sureste de Madrid, Madrid, , Spain
Salford Royal NHS Foundation Trust, Manchester, , United Kingdom
Name: D.L. van der Peet, MD, PhD
Affiliation: VU Medisch Centrum
Role: PRINCIPAL_INVESTIGATOR